Analyst Ratings For Immunomedics (NASDAQ:IMMU)
Today, Cowen and Company reiterated its Outperform rating on Immunomedics (NASDAQ:IMMU) with a price target of $15.00.
There are 3 buy ratings on the stock.
The current consensus rating on Immunomedics (NASDAQ:IMMU) is Buy (Score: 3.00) with a consensus target price of $13.00 per share, a potential 45.90% upside.
Some recent analyst ratings include
- 7/24/2017-Cowen and Company Reiterated Rating of Outperform.
- 7/14/2017-Jefferies Group LLC Reiterated Rating of Buy.
- 5/5/2017-Wells Fargo & Company Upgrade from a “Market Perform ” rating to a ” Outperform” rating.
- 7/29/2015-Oppenheimer Holdings, Inc. Reiterated Rating of Outperform.
Recent Insider Trading Activity For Immunomedics (NASDAQ:IMMU)
Immunomedics (NASDAQ:IMMU) has insider ownership of 6.60% and institutional ownership of 62.02%.
- On 8/24/2016 Don C Stark, Director, sold 9,900 with an average share price of $2.97 per share and the total transaction amounting to $29,403.00. View SEC Filing
- On 8/23/2016 Mary E Paetzold, Director, sold 15,000 with an average share price of $2.98 per share and the total transaction amounting to $44,700.00. View SEC Filing
- On 6/13/2016 Cynthia L Goldenberg, CEO, sold 371,990 with an average share price of $3.03 per share and the total transaction amounting to $1,127,129.70. View SEC Filing
- On 6/8/2016 Cynthia L Goldenberg, CEO, sold 41,441 with an average share price of $3.62 per share and the total transaction amounting to $150,016.42. View SEC Filing
- On 6/8/2016 David M Goldenberg, Chairman, sold 353,010 with an average share price of $3.88 per share and the total transaction amounting to $1,369,678.80. View SEC Filing
- On 6/7/2016 Cynthia L Goldenberg, CEO, sold 4,600 with an average share price of $4.01 per share and the total transaction amounting to $18,446.00. View SEC Filing
- On 6/7/2016 David M Goldenberg, Chairman, sold 12,300 with an average share price of $3.98 per share and the total transaction amounting to $48,954.00. View SEC Filing
Recent Trading Activity for Immunomedics (NASDAQ:IMMU)
Shares of Immunomedics closed the previous trading session at 8.91 up +0.25 2.89% with 1,732,629 shares trading hands.